Savoldo, Barbara <br/><br/>
Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Mar 2005 
 - 566-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2004.00693.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--pharmacology<br/>Child<br/>Child, Preschool<br/>DNA, Viral--metabolism<br/>Epstein-Barr Virus Infections--immunology<br/>Female<br/>Herpesvirus 4, Human--genetics<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Liver Transplantation<br/>Lymphoproliferative Disorders--drug therapy<br/>Male<br/>Rituximab<br/>Time Factors